IN201641026603A - - Google Patents
Info
- Publication number
- IN201641026603A IN201641026603A IN201641026603A IN201641026603A IN201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A IN 201641026603 A IN201641026603 A IN 201641026603A
- Authority
- IN
- India
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201641026603A IN201641026603A (zh) | 2016-08-04 | 2016-08-04 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201641026603A IN201641026603A (zh) | 2016-08-04 | 2016-08-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN201641026603A true IN201641026603A (zh) | 2018-02-09 |
Family
ID=87975954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN201641026603A IN201641026603A (zh) | 2016-08-04 | 2016-08-04 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN201641026603A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114214375A (zh) * | 2021-12-27 | 2022-03-22 | 江苏威凯尔医药科技有限公司 | (r)-3-(4-卤代-1h-吡唑-1-基)-3-环戊基丙酸酯的制备方法 |
US11897889B2 (en) | 2020-08-18 | 2024-02-13 | Incyte Corporation | Process and intermediates for preparing a JAK1 inhibitor |
US11905292B2 (en) | 2020-08-18 | 2024-02-20 | Incyte Corporation | Process and intermediates for preparing a JAK inhibitor |
-
2016
- 2016-08-04 IN IN201641026603A patent/IN201641026603A/en unknown
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11897889B2 (en) | 2020-08-18 | 2024-02-13 | Incyte Corporation | Process and intermediates for preparing a JAK1 inhibitor |
US11905292B2 (en) | 2020-08-18 | 2024-02-20 | Incyte Corporation | Process and intermediates for preparing a JAK inhibitor |
CN114214375A (zh) * | 2021-12-27 | 2022-03-22 | 江苏威凯尔医药科技有限公司 | (r)-3-(4-卤代-1h-吡唑-1-基)-3-环戊基丙酸酯的制备方法 |
WO2023125373A1 (zh) * | 2021-12-27 | 2023-07-06 | 江苏威凯尔医药科技有限公司 | 芦可替尼及其中间体的制备方法 |
CN114214375B (zh) * | 2021-12-27 | 2024-03-19 | 江苏威凯尔医药科技有限公司 | (r)-3-(4-卤代-1h-吡唑-1-基)-3-环戊基丙酸酯的制备方法 |